Food and Drug Administration (FDA) approved some GLP-1 medications, including semaglutide and liraglutide, for weight management in obese patients
Most are manageable and improve with time
#PharmaStrategy #MedicoMarketing #MedicalAffairs #PharmaLeadership #GLP1 #DiabetesCare #ObesityManagement #HealthcareInnovation #PharmaIndia #EmergingMarkets #MarketAccess #PharmaCommercial #HealthcareLeadership #IndianPharmaLeaders
This might occur in complex cases where other treatment options are limited due to contraindications, intolerances, or patient-specific factors
Furthermore, polyphenols like quercetin and catechins have been observed to influence mitochondrial potential and help maintain the optimal electron transport chain function, which is crucial for ATP production [103, 104]
Insurance companies are really making it very difficult for patients to get access to these drugs, said Dr